Translate

Needle-Free Drug Delivery :CAGR of 10.31% by 2018-21 Market | Competitive landscape and key vendors - Endo Pharmaceuticals, Antares Pharma, Inovio Pharmaceuticals

Press Release - 27 April 2018
Global Research and Development News --
. .
Report Description-
' '
About Needle Free Drug Delivery
Needle free drug delivery technologies are used to deliver biologics such as insulin, vaccines, human growth hormone (HGH), and drugs for pain management into the patient’s body without using a traditional needle. Needle free drug delivery market includes jet injectors, transdermal drug delivery systems and other novel needle free devices that are used as alternatives to conventional needle drug delivery devices.
Technavio’s analysts forecast the global needle free drug delivery market to grow at a CAGR of 10.31% during the period 2017-2021.
. .
Get Sample Report https://www.researchmoz.us/enquiry.php?type=S&repid=1166479
' '
Covered in this report
The report covers the present scenario and the growth prospects of the global needle free drug delivery market for 2017-2021. To calculate the market size, the report considers sales and value.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Needle Free Drug Delivery Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Endo Pharmaceuticals
• Antares Pharma
• Inovio Pharmaceuticals
• Valeritas
• PharmaJet
Other prominent vendors
• 3M
• Akra Dermojet
• Consort Medical
• CROSSJECT
• Injex Pharma (acquired by Hangzhou Hema Medical Equipment)
• PenJet Corporation
• Zosano
• D’Antonio Consultants International
• European Pharma Group
Market driver
• Increasing incidence of needle stick injuries
• For a full, detailed list, view our report
Market challenge
• Technical complexities of needle free drug delivery devices
• For a full, detailed list, view our report
Market trend
• Increasing outsourcing
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
. .
' '
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by product/technology
• Jet injectors
• Market size and forecast
• Transdermal drug delivery systems
• Market size and forecast
• Others
• Market size and forecast
PART 07: Market segmentation by application
• Market segmentation by application
• Insulin delivery
• Vaccination
• Pain management
• Others
PART 08: Geographical segmentation
• Market overview
• Americas
• EMEA
• APAC
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Market challenges
PART 11: Market trends
• Technological innovations
• Increasing outsourcing
• M&A and strategic collaborations
PART 12: Vendor landscape
• Competitive scenario
PART 13: Key vendor analysis
• Endo Pharmaceuticals
• Antares Pharma
• Inovio Pharmaceuticals
• Valeritas
• PharmaJet
• Other prominent vendors
PART 14: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Global needle free drug delivery market: Segmentation overview
Exhibit 02: Global needle free drug delivery market 2016-2021 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global needle free drug delivery market by product/technology
Exhibit 05: Global needle free drug delivery market share by product/technology 2016 (%)
Exhibit 06: Jet injectors in market
Exhibit 07: Jet injectors in development
Exhibit 08: Global jet injectors market 2016-2021: Overview
Exhibit 09: Global jet injectors market 2016-2021 ($ billions)
Exhibit 10: Microneedle drug delivery systems in market
Exhibit 11: Microneedle drug delivery systems in development
Exhibit 12: Iontophoresis drug delivery systems in market
Exhibit 13: Global transdermal drug delivery systems market 2016-2021: Overview
Exhibit 14: Global transdermal needle free drug delivery systems market 2016-2021 ($ billions)
Exhibit 15: Other drug delivery systems in market
Exhibit 16: Global other needle free drug delivery devices market 2016-2021 ($ billions)
Exhibit 17: Global needle free drug delivery market by application
Exhibit 18: Global needle free drug delivery market share by application 2016 (%)
Exhibit 19: Needle free insulin delivery systems in market
Exhibit 20: Needle free insulin delivery systems in development
Exhibit 21: Needle free vaccine delivery systems in market
Exhibit 22: Needle free vaccine delivery systems in development
Exhibit 23: Global needle free drug delivery market by geography 2016 (%)
Exhibit 24: Needle free drug delivery market in Americas 2016-2021 ($ billions)
Exhibit 25: Needle free drug delivery market in EMEA 2016-2021 ($ billions)
Exhibit 26: Needle free drug delivery market in APAC 2016-2021 ($ billions)
Exhibit 27: Endo International: Key highlights
Exhibit 28: Endo International: Strength assessment
Exhibit 29: Endo International: Strategy assessment
Exhibit 30: Endo International: Opportunity assessment
Exhibit 31: Antares Pharma: Key highlights
Exhibit 32: Antares Pharma: Strength assessment
Exhibit 33: Antares Pharma: Strategy assessment
Exhibit 34: Antares Pharma: Opportunity assessment
Exhibit 35: Inovio Pharmaceuticals: Key highlights
Exhibit 36: Inovio Pharmaceuticals: Strength assessment
Exhibit 37: Inovio Pharmaceuticals: Strategy assessment
Continue.....

Comments